Liver Cancer Survival Rates After Surgery for Intermediate Stages

For patients diagnosed with intermediate-stage liver cancer, timely surgical intervention can significantly improve survival outcomes. Studies indicate that the survival rate after surgery can range between 30% to 50%, with some patients living up to 3 to 5 years post-operation. When liver cancer is detected early, the most effective treatment remains surgical removal of the tumor to reduce the overall cancer burden in the body.

However, in many clinical cases, patients are often diagnosed at a late or advanced stage, where surgery may not be the best option. In such situations, alternative treatments like interventional therapies can help slow the progression of the disease. These include procedures such as transarterial chemoembolization (TACE), radiofrequency ablation (RFA), or hepatic arterial infusion chemotherapy.

Even after successful surgery for intermediate-stage liver cancer, there remains a risk of recurrence. Some patients may experience local tumor regrowth or distant metastasis within approximately three years after the operation. This highlights the importance of ongoing monitoring and follow-up care to detect any signs of recurrence early.

In conclusion, while surgery offers a promising survival benefit for intermediate-stage liver cancer patients, combining it with other treatment modalities and regular post-operative evaluations can enhance long-term outcomes. Early detection and personalized treatment plans play a crucial role in improving prognosis and quality of life.